Using proprietary technology Ultivue offers clinical scientists and researchers with the ability to understand the complex tumor micro-environment.
With the application of DNA-barcoded antibodies multiplex biomarker assays for tissue phenotyping and digital pathology are now so much easier.
Ultivue’s proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research.
Ultivue’s highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs.
